Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nanopartiele Drug Delivery System (NDDS) Market by Type (Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others), By Application (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nanopartiele Drug Delivery System (NDDS) Market by Type (Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others), By Application (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 202975 3300 Pharma & Healthcare 377 244 Pages 4.9 (41)
                                          

Market Overview:


The global nanopartiele drug delivery system (NDDS) market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for targeted and personalized medicine, and technological advancements in NDDS. Based on type, the nanopartiele drug delivery system (NDDS) market can be segmented into nanocrystals, nanoparticles, liposomes, micelles, nanotubes, and others. Nanoparticles are expected to account for the largest share of the global NDDS market in 2018 owing to their ability to encapsulate large payloads of drugs and their versatile applications across various therapeutic areas. By application area, neurology is expected to account for the largest share of the global NDDS market in 2018 followed by oncology. The large share of this segment can be attributedto growing incidence ratesof neurological disorders such as Alzheimer’sand Parkinson’s diseaseand increasing demand for novel therapiesfor these conditions.


Global Nanopartiele Drug Delivery System (NDDS) Industry Outlook


Product Definition:


Nanoparticle drug delivery systems (NDDS) are systems that use nanoparticles to deliver drugs to a target site. NDDS can improve the efficacy and safety of drugs by increasing their bioavailability, targeting them to specific cells or tissues, and reducing their toxicity.


Nanocrystals:


Nanocrystals are nanoparticles that can be crystalline or amorphous in nature. They have unique physical and chemical properties which differentiate them from conventional bulk materials. Nanocrystals possess the potential to revolutionize a wide range of applications including medical, optoelectronics, catalysis, construction and packaging among others.


Nanoparticles:


Nanoparticles are at the confluence of several trends in science and technology. Nanoparticles have gained significant attention in drug delivery systems over the past decade. The nanoparticle-based drug delivery system has been a subject of extensive research and is currently gaining momentum across various industries including pharmaceuticals, cosmetics, agrochemicals, etc.


Application Insights:


On the basis of application, the global nanopartiele drug delivery system (NDDS) market has been segmented into neurology, oncology, cardiovascular/physiology, anti-inflammatory/immunology and anti-infective. The cardiovascular/physiology segment held the largest share in 2017 owing to increasing product usage for treating diseases such as heart attacks and strokes.


The growing prevalence of neurological disorders coupled with rising geriatric population is expected to drive demand over the forecast period. For instance, as per a United Nations (UN) study published in 2016; it was estimated that there will be approximately 1 billion older people by 2030 globally which in turn is expected to boost demand for advanced therapeutics including nanotechnology driven drugs delivery systems over next few years.


The other applications include diabetes mellitus type 2.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of a large number of nanoparticiele drug delivery systems manufacturers and research institutes in this region. The U.S.-based companies are involved in extensive R&D activities for developing novel nanoparticles that exhibit favorable characteristics, such as enhanced efficacy and reduced toxicity over existing therapeutics.


Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments along with an increase in awareness regarding advanced therapies among patients & physicians which is likely to fuel demand for nanotechnology-based products over next eight years (from 2018 - 2030).


Growth Factors:


  • Increasing demand for targeted drug delivery: The key advantage of nanoparticulate drug delivery is its ability to target specific cells or tissues, thus reducing the side effects of the drugs. This is expected to drive the demand for nanoparticulate drug delivery systems in the coming years.
  • Growing prevalence of chronic diseases: The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is expected to boost the demand for nanoparticulate drug delivery systems in the near future.
  • Rising R&D expenditure by pharmaceutical companies: Pharmaceutical companies are investing heavily in R&D activities to develop novel nanotechnology-based therapies and products. This is likely to propel the growth of NDDS market in coming years.
  • Technological advancements: Rapid technological advancements are taking place across various industries including healthcare sector that would help improve performance and efficacy of NDDS products/systems over traditional therapies/drugs thereby fueling their adoption rates across major markets globally5 Emerging economies offer lucrative opportunities: A large number of emerging economies such as China, India, Brazil offer lucrative opportunities for growth owing to increasing awareness about benefits associated with using NDDS products among patients as well as healthcare professionals

Scope Of The Report

Report Attributes

Report Details

Report Title

Nanopartiele Drug Delivery System (NDDS) Market Research Report

By Type

Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others

By Application

Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others

By Companies

Pfizer, Inc., AbbVie, Inc., Merck & Co., Inc., Johnson & Johnson , Roche, Bayer, Novartis International AG, Celgene Corporation, Capsulution Pharma, Perrigo Company plc, Amgen Inc., Teva Pharmaceutical Industries Ltd

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

244

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Nanopartiele Drug Delivery System (NDDS) Market Report Segments:

The global Nanopartiele Drug Delivery System (NDDS) market is segmented on the basis of:

Types

Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pfizer, Inc.
  2. AbbVie, Inc.
  3. Merck & Co., Inc.
  4. Johnson & Johnson 
  5. Roche
  6. Bayer
  7. Novartis International AG
  8. Celgene Corporation
  9. Capsulution Pharma
  10. Perrigo Company plc
  11. Amgen Inc.
  12. Teva Pharmaceutical Industries Ltd

Global Nanopartiele Drug Delivery System (NDDS) Market Overview


Highlights of The Nanopartiele Drug Delivery System (NDDS) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Nanocrystals
    2. Nanoparticles
    3. Liposomes
    4. Micelles
    5. Nanotubes
    6. Others
  1. By Application:

    1. Neurology
    2. Oncology
    3. Cardiovascular/Physiology
    4. Anti-inflammatory/Immunology
    5. Anti-infective
    6. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nanopartiele Drug Delivery System (NDDS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nanopartiele Drug Delivery System (NDDS) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A nanopartiele drug delivery system (NDDS) is a technology that uses nanoparticles to improve the efficacy and safety of drugs. Nanoparticles are small, but powerful, pieces of matter that have been engineered to be smaller than 100 nanometers in size. They can travel through the body more easily than larger particles and can reach specific areas where they are needed most. This makes them an attractive option for delivering drugs to specific parts of the body, such as the brain or lungs.

Some of the key players operating in the nanopartiele drug delivery system (ndds) market are Pfizer, Inc., AbbVie, Inc., Merck & Co., Inc., Johnson & Johnson‚ , Roche, Bayer, Novartis International AG, Celgene Corporation, Capsulution Pharma, Perrigo Company plc, Amgen Inc., Teva Pharmaceutical Industries Ltd.

The nanopartiele drug delivery system (ndds) market is expected to grow at a compound annual growth rate of 10.8%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Nanopartiele Drug Delivery System (NDDS) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Nanopartiele Drug Delivery System (NDDS) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Nanopartiele Drug Delivery System (NDDS) Market - Supply Chain
   4.5. Global Nanopartiele Drug Delivery System (NDDS) Market Forecast
      4.5.1. Nanopartiele Drug Delivery System (NDDS) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Nanopartiele Drug Delivery System (NDDS) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Nanopartiele Drug Delivery System (NDDS) Market Absolute $ Opportunity

5. Global Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Type
      5.3.1. Nanocrystals
      5.3.2. Nanoparticles
      5.3.3. Liposomes
      5.3.4. Micelles
      5.3.5. Nanotubes
      5.3.6. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Application
      6.3.1. Neurology
      6.3.2. Oncology
      6.3.3. Cardiovascular/Physiology
      6.3.4. Anti-inflammatory/Immunology
      6.3.5. Anti-infective
      6.3.6. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Nanopartiele Drug Delivery System (NDDS) Demand Share Forecast, 2019-2026

9. North America Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Application
      9.4.1. Neurology
      9.4.2. Oncology
      9.4.3. Cardiovascular/Physiology
      9.4.4. Anti-inflammatory/Immunology
      9.4.5. Anti-infective
      9.4.6. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Type
      9.7.1. Nanocrystals
      9.7.2. Nanoparticles
      9.7.3. Liposomes
      9.7.4. Micelles
      9.7.5. Nanotubes
      9.7.6. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Nanopartiele Drug Delivery System (NDDS) Demand Share Forecast, 2019-2026

10. Latin America Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Application
      10.4.1. Neurology
      10.4.2. Oncology
      10.4.3. Cardiovascular/Physiology
      10.4.4. Anti-inflammatory/Immunology
      10.4.5. Anti-infective
      10.4.6. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Type
      10.7.1. Nanocrystals
      10.7.2. Nanoparticles
      10.7.3. Liposomes
      10.7.4. Micelles
      10.7.5. Nanotubes
      10.7.6. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Nanopartiele Drug Delivery System (NDDS) Demand Share Forecast, 2019-2026

11. Europe Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Application
      11.4.1. Neurology
      11.4.2. Oncology
      11.4.3. Cardiovascular/Physiology
      11.4.4. Anti-inflammatory/Immunology
      11.4.5. Anti-infective
      11.4.6. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Type
      11.7.1. Nanocrystals
      11.7.2. Nanoparticles
      11.7.3. Liposomes
      11.7.4. Micelles
      11.7.5. Nanotubes
      11.7.6. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Nanopartiele Drug Delivery System (NDDS) Demand Share, 2019-2026

12. Asia Pacific Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Application
      12.4.1. Neurology
      12.4.2. Oncology
      12.4.3. Cardiovascular/Physiology
      12.4.4. Anti-inflammatory/Immunology
      12.4.5. Anti-infective
      12.4.6. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Type
      12.7.1. Nanocrystals
      12.7.2. Nanoparticles
      12.7.3. Liposomes
      12.7.4. Micelles
      12.7.5. Nanotubes
      12.7.6. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Nanopartiele Drug Delivery System (NDDS) Demand Share, 2019-2026

13. Middle East & Africa Nanopartiele Drug Delivery System (NDDS) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Application
      13.4.1. Neurology
      13.4.2. Oncology
      13.4.3. Cardiovascular/Physiology
      13.4.4. Anti-inflammatory/Immunology
      13.4.5. Anti-infective
      13.4.6. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Nanopartiele Drug Delivery System (NDDS) Market Size and Volume Forecast by Type
      13.7.1. Nanocrystals
      13.7.2. Nanoparticles
      13.7.3. Liposomes
      13.7.4. Micelles
      13.7.5. Nanotubes
      13.7.6. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Nanopartiele Drug Delivery System (NDDS) Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Nanopartiele Drug Delivery System (NDDS) Market: Market Share Analysis
   14.2. Nanopartiele Drug Delivery System (NDDS) Distributors and Customers
   14.3. Nanopartiele Drug Delivery System (NDDS) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pfizer, Inc.
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. AbbVie, Inc.
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Merck & Co., Inc.
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Johnson & Johnson 
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Roche
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Bayer
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Novartis International AG
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Celgene Corporation
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Capsulution Pharma
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Perrigo Company plc
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Amgen Inc.
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Teva Pharmaceutical Industries Ltd
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
    &nbs

Our Trusted Clients

Contact Us